Current Pharmaceutical Biotechnology

Editor-in-Chief

Nikolaos Labrou
Department of Biotechnology
Agricultural University of Athens
Athens
(Greece)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor



Editorial: [Hot Topic: Drug Development in Dermatology: New Targets for Old Diseases?] free to download

Volume:13   Issue: 10
Pp: 1859-1860
Riccardo G. Borroni
DOI: 10.2174/138920112802273317
Published on: 23 July, 2012

Psoriasis, from Pathogenesis to Therapeutic Strategies: IL-21 as a Novel Potential Therapeutic Target

Volume:13   Issue: 10
Pp: 1861-1867
Elisabetta Botti, Giulia Spallone, Roberta Caruso, Giovanni Monteleone, Sergio Chimenti and Antonio Costanzo
DOI: 10.2174/138920112802273281
Published on: 23 July, 2012

Gene Therapy of Skin Adhesion Disorders (Mini Review)

Volume:13   Issue: 10
Pp: 1868-1876
Alessia Cavazza and Fulvio Mavilio
DOI: 10.2174/138920112802273119
Published on: 23 July, 2012

Apoptotic Pathways in the Pathogenesis of Pemphigus: Targets for New Therapies

Volume:13   Issue: 10
Pp: 1877-1881
Roberta Lotti, Alessandra Marconi and Carlo Pincelli
DOI: 10.2174/138920112802273236
Published on: 23 July, 2012

Role of Defensins and Cathelicidin LL37 in Auto-Immune and Auto- Inflammatory Diseases

Volume:13   Issue: 10
Pp: 1882-1897
Loredana Frasca and Roberto Lande
DOI: 10.2174/138920112802273155
Published on: 23 July, 2012

New Pharmaceutical Concepts for Sebaceous Gland Diseases: Implementing Today’s Pre-Clinical Data into Tomorrow’s Daily Clinical Practice

Volume:13   Issue: 10
Pp: 1898-1913
Vasiliki A. Zampeli, Evgenia Makrantonaki, Thrasivoulos Tzellos and Christos C. Zouboulis
DOI: 10.2174/138920112802273173
Published on: 23 July, 2012



Editorial: [Hot Topic: Antidotes and Rescue Therapies] free to download

Volume:13   Issue: 10
Pp: 1914-1916
Richard Y. Wang and Ziad N. Kazzi
DOI: 10.2174/138920112802273164
Published on: 23 July, 2012

Acetylcysteine Therapy for Acetaminophen Poisoning

Volume:13   Issue: 10
Pp: 1917-1923
Kennon Heard and Jody Green
DOI: 10.2174/138920112802273146
Published on: 23 July, 2012

Antidote Control of Aptamer Therapeutics: The Road to a Safer Class of Drug Agents

Volume:13   Issue: 10
Pp: 1924-1934
K. M. Bompiani, R. S. Woodruff, R. C. Becker, S. M. Nimjee and B. A. Sullenger
DOI: 10.2174/138920112802273137
Published on: 23 July, 2012

Black Widow Spider (Latrodectus mactans) Antivenom in Clinical Practice

Volume:13   Issue: 10
Pp: 1935-1939
Andrew A. Monte
DOI: 10.2174/138920112802273335
Published on: 23 July, 2012

Antidotes for Acute Cyanide Poisoning

Volume:13   Issue: 10
Pp: 1940-1948
Stephen W. Borron and Frederic J. Baud
DOI: 10.2174/138920112802273182
Published on: 23 July, 2012

Calcium and Zinc DTPA Administration for Internal Contamination with Plutonium-238 and Americium-241

Volume:13   Issue: 10
Pp: 1957-1963
Ziad N. Kazzi, Alexander Heyl and Johann Ruprecht
DOI: 10.2174/138920112802273308
Published on: 23 July, 2012

Legalon® SIL: The Antidote of Choice in Patients with Acute Hepatotoxicity from Amatoxin Poisoning open access plus

Volume:13   Issue: 10
Pp: 1964-1970
Ulrich Mengs, Ralf - Torsten Pohl and Todd Mitchell
DOI: 10.2174/138920112802273353
Published on: 23 July, 2012

Reactive Skin Decontamination Lotion (RSDL) for the Decontamination of Chemical Warfare Agent (CWA) Dermal Exposure

Volume:13   Issue: 10
Pp: 1971-1979
M. D. Schwartz, C. G. Hurst, M. A. Kirk, S. J.D. Reedy and E. H. Braue
DOI: 10.2174/138920112802273191
Published on: 23 July, 2012

Antivenoms for Snakebite: Design, Function, and Controversies

Volume:13   Issue: 10
Pp: 1980-1986
Eric J. Lavonas
DOI: 10.2174/138920112802273227
Published on: 23 July, 2012



Editorial: [Hot Topic: Primary Sjogren’s Syndrome Research and Therapy: Has a New Dawn Arrived?] free to download

Volume:13   Issue: 10
Pp: 1987-1988
Wan-Fai Ng
DOI: 10.2174/138920112802273272
Published on: 23 July, 2012

Biologic Therapies in Primary Sjögren's Syndrome

Volume:13   Issue: 10
Pp: 1997-2008
S. J. Bowman
DOI: 10.2174/138920112802273263
Published on: 23 July, 2012

Local Activation and Systemic Dysregulation of T Lymphocytes in Sjögren’s Syndrome

Volume:13   Issue: 10
Pp: 2009-2021
Robert Busch, Andreas V. Hadjinicolaou and Frances C. Hall
DOI: 10.2174/138920112802273092
Published on: 23 July, 2012

Primary Sjogren’s Syndrome: Time for Prospective Cohorts

Volume:13   Issue: 10
Pp: 2022-2025
Jacques-Eric Gottenberg and Xavier Mariette
DOI: 10.2174/138920112802273128
Published on: 23 July, 2012

Current and Future Challenges in Primary Sjogren’s Syndrome

Volume:13   Issue: 10
Pp: 2026-2045
Arjan Vissink, Hendrika Bootsma, Fred KL Spijkervet, Shen Hu, David T Wong and Cees GM Kallenberg
DOI: 10.2174/138920112802273254
Published on: 23 July, 2012

Epigenetics and Sjogren’s Syndrome

Volume:13   Issue: 10
Pp: 2046-2053
Christelle Le Dantec, Marie-Michele Varin, Wesley H Brooks, Jacques-Olivier Pers, Pierre Youinou and Yves Renaudineau
DOI: 10.2174/138920112802273326
Published on: 23 July, 2012

Primary Sjogren’s Syndrome and the Type I Interferon System

Volume:13   Issue: 10
Pp: 2054-2062
Gunnel Nordmark, Maija-Leena Eloranta and Lars Ronnblom
DOI: 10.2174/138920112802273290
Published on: 23 July, 2012

Autoantibodies and Sjogren’s Syndrome: A Physiologist’s Perspective

Volume:13   Issue: 10
Pp: 2063-2070
Peter M. Smith and Luke J. Dawson
DOI: 10.2174/138920112802273218
Published on: 23 July, 2012

B-Lymphocytes Govern the Pathogenesis of Sjogren's Syndrome

Volume:13   Issue: 10
Pp: 2071-2077
Pierre Youinou, Alain Saraux and Jacques-Olivier Pers
DOI: 10.2174/138920112802273100
Published on: 23 July, 2012

Principles and Applications of Selective Biophysical Methods for Characterization and Comparability Assessment of a Monoclonal Antibody

Volume:13   Issue: 10
Pp: 2078-2101
Haripada Maity, Yin Lai, Arvind Srivastava and Joel Goldstein
DOI: 10.2174/138920112802273344
Published on: 23 July, 2012